- Home
- WEN vs SRPT Comparison
WEN vs SRPT Comparison
Compare WEN & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEN
- SRPT
- Stock Information
- Founded
- WEN 1969
- SRPT 1980
- Country
- WEN United States
- SRPT United States
- Employees
- WEN N/A
- SRPT N/A
- Industry
- WEN Restaurants
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- WEN Consumer Discretionary
- SRPT Health Care
- Exchange
- WEN Nasdaq
- SRPT Nasdaq
- Market Cap
- WEN 2.1B
- SRPT 1.7B
- IPO Year
- WEN N/A
- SRPT 1997
- Fundamental
- Price
- WEN $10.57
- SRPT $21.81
- Analyst Decision
- WEN Hold
- SRPT Hold
- Analyst Count
- WEN 17
- SRPT 29
- Target Price
- WEN $13.97
- SRPT $45.65
- AVG Volume (30 Days)
- WEN 7.9M
- SRPT 19.4M
- Earning Date
- WEN 08-08-2025
- SRPT 08-06-2025
- Dividend Yield
- WEN 5.30%
- SRPT N/A
- EPS Growth
- WEN N/A
- SRPT N/A
- EPS
- WEN 0.96
- SRPT N/A
- Revenue
- WEN $2,225,413,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- WEN N/A
- SRPT $3.52
- Revenue Next Year
- WEN $4.01
- SRPT N/A
- P/E Ratio
- WEN $11.01
- SRPT N/A
- Revenue Growth
- WEN 1.31
- SRPT 64.89
- 52 Week Low
- WEN $9.74
- SRPT $10.42
- 52 Week High
- WEN $20.60
- SRPT $144.22
- Technical
- Relative Strength Index (RSI)
- WEN 51.47
- SRPT 61.42
- Support Level
- WEN $9.97
- SRPT $17.28
- Resistance Level
- WEN $10.45
- SRPT $20.61
- Average True Range (ATR)
- WEN 0.30
- SRPT 1.62
- MACD
- WEN 0.10
- SRPT 1.05
- Stochastic Oscillator
- WEN 83.84
- SRPT 95.85
About WEN Wendy's Company (The)
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.